medigraphic.com
ISSN 1560-4381 (Print)

2015, Number 3

<< Back Next >>

Correo Científico Médico 2015; 19 (3)

Evans Fisher syndrome

Silva RM, Urribastera CA, Fernández RL, del Socorro M, Portelles MA

Language: Spanish
References: 9
Page: 536-541
PDF size: 232.87 Kb.


ABSTRACT

Evans Fisher Syndrome was described in 1951 by Robert Evans, defined as an atypical immune disorder and infrequent caused by antibodies against membrane antigen of red cells and platelets with hemorrhagic manifestations in skin and mucous membranes, generally evolving not always favorable prone chronicity and frequent referrals. A patient whose diagnosis was made to determine the presence of antibodies against blood cells mentioned before in childhood (at nine months) with an unfavorable evolution that led to several admissions at intensive care. Now the patient is 15 years and has 11 weeks of gestation and presented important episodes of hemolysis, steroid treatment was not effective so to interrupt the pregnancy was necessary in order to preserve the life of the mother.


REFERENCES

  1. Macías Garrido E, Hurtado Monroy R, Vargas Viver P. Síndrome de Evans refractario con respuesta a anti-CD 20. Act Méd Grupo Ángeles. 2007 [citado 12 may 2014]; 5(4): 209-213. Disponible en: http://www.medigraphic.com/pdfs/actmed/am-2007/am074e.pdf

  2. Ferrer Machín M, González Trebejo M, Dueñas Rosquete L, Duarte Vilariño A, González Dalmau L. Síndrome de FISHER–EVANS, debut de un Lupus Eritematoso Sistémico. Mediciego. 2006 [citado 12 abr 2014]; 12(1) Disponible en: http://bvs.sld.cu/revistas/mciego/vol12_supl1_06/casos/c11_v12_supl106.html

  3. Pérez Rojas JJ, Da Silva De Abreu AJ. Síndrome de Evans de evolución crónica en una paciente pediátrica femenina. Act Cient Estud. 2010 [citado 12 may 2014]; 8(3):83-85. Disponible en: www.medigraphic.com/pdfs/estudiantil/ace-2010/ace103g.pdf

  4. Larquin Comet JI, Risco Almenares GM, Alarcón Martínez Y, Álvarez Hidalgo R. Síndrome de Evans. Reporte de un caso. AMC. 2008 [citado 2014 mar 25]; 12(1) Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-02552008000100014&lang=pt

  5. Romero González A, Gil Agramante M, Ortiz Labrada A, Tamayo Rodríguez M, Álvarez Feliciano W, Suárez Castillo JC, et al. Síndrome de Evans Fisher asociado a Esclerodermia. Rev Cubana Hematol Inmunol Hemoter. 2014 [citado 19 may 2014]; 30 (1). Disponible en: http://www.revhematologia.sld.cu/index.php/hih/article/view/113/107

  6. Barboza Retana J, Bogantes Ledesma P, Carballo Gutiérrez W, Díaz Camacho J. Síndrome de Evans de aparición súbita en el embarazo. Acta méd costarric. 2011 [citado 19 may 2014]; 53 (4) Disponible en: http://www.scielo.sa.cr/scielo.php?pid=S0001-60022011000400010&script=sci_arttext

  7. Larquin Comet JI, Risco Almenares GM, Alarcón Martínez Y, Álvarez Hidalgo R. Síndrome de Evans. Reporte de un caso. Arch Médic Camagüey. 2008 [citado 19 may 2014]; 12 (1) Disponible en: http://scielo.sld.cu/pdf/amc/v12n1/amc14108.pdf

  8. Brito AA, Calheiros Leite LA, Maysa Martin R, Wagner da Silva Ramos F, Medeiros Beder Reis S. Ocorrência simultânea de síndrome de Evans e anemia falciforme em uma criança de 2 anos. J Bras Patol Med Lab. 2012 [citado 19 de mayo de 2014]; 48 (2).Disponible en: http://www.scielo.br/scielo.php?pid=S1676-24442012000200005&script=sci_arttext

  9. Carey EJ, Somaratne K, Rakela J. Successful rituximab therapy in refractory autoimmune hepatitis and Evans syndrome. Rev Med Chile. 2011 [citado 19 may 2014]; 139 (11): 1484-1487. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872011001100015




2020     |     www.medigraphic.com